We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Down 9% on Oct 30, a down day for the market: the S&P 500 fell 2%, 71% of stocks fell, and medical device stocks a median 3%.
| The company | Profit up 11% to $1.6B |
| Latest filing | 10-Q, Oct 30 |
Sun Nov 15: Annual meeting, onlineProxy filed Oct 1.
1 more date ahead: dividend dates, for Pro members.
After its last 4 reports it closed -4.5% on average, higher 1 of 4 times.
Averagefor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means
RMD is #39 of 84 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 39 |
Expected to report Thu Jan 28, after the close (in 79 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $1.4B, 6% more than a year ago; a profit of $2.92 a share, from $2.37.
“Non-GAAP operating margin of 35.8% and non-GAAP diluted earnings per share of $2.91, up 14% year-over-year, predominantly attributable to strong revenue growth and gross margin improvement.”
| Line | Q1 FY27 | Q1 FY26 |
|---|---|---|
| Sleep and Breathing Health | $1.3B | $1.2B |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Oct 30)
No outlook figures read from this release.
Sales grew 12% a year over 5 years, fiscal 2021 to 2026.
Pays $2.64 a share a year.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Oct 29, 2026 | -2.5% | -9.1% | -5.3% |
| Aug 6, 2026 | -7.2% | -5.1% | +1.6% |
| Apr 30, 2026 | -3.6% | -4.1% | -3.2% |
Sales grew every year from 2019 to 2026, to $5.7B. It made a profit in each of the eight years.
RSI 47.2, MACD below signal, above both averages. Not scored.
Its dividends come to 24% of its free cash flow.
| Dividend | $2.64 a share a year |
| Paid out | About $379M a year |
| Free cash flow | $1.6B |
| Record | Raised each of the last 6 years |
18 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: RMD is 0.1% of VIG, 0.1% of SCHG, and under 0.1% of DGRO, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jul 31 to Aug 31, 2026.
ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care software the remainder. Growth depends on diagnosing more of the large untreated sleep apnea population and moving them onto therapy. The Americas contribute about two-thirds of device and mask revenue, with most of the rest from Europe, Japan, and Australia.
“Global competition for sales of our products and services is intense.”
RMD scores 6 today, which Breakaway calls Average. It is #39 of 84 in Medical Devices by Quality Score, with 2 of 14 chart checks firing. Down 9% on Oct 30, a down day for the market: the S&P 500 fell 2%, 71% of stocks fell, and medical device stocks a median 3%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
RMD scores 6 today, which Breakaway calls Average (6 to 10). That is #39 of 84 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind RMD's 6.
Expected to report Thu Jan 28, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. RMD closed higher after 1 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.